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Recently, the rs6232 (N221D) and rs6235 (S690T) SNPs in the PCSK1 gene were associated with obesity in a
meta-analysis comprising more than 13 000 individuals of European ancestry. Each additional minor allele of
rs6232 or rs6235 was associated with a 1.34- or 1.22-fold increase in the risk of obesity, respectively. So far,
only one relatively small study has aimed to replicate these ﬁndings, but could not conﬁrm the association of
the rs6235 SNP and did not study the rs6232 variant. In the present study, we examined the associations
of the rs6232 and rs6235 SNPs with obesity in a population-based cohort consisting of 20 249 individuals
of European descent from Norfolk, UK. Logistic regression and generalized linear models were used to
test the associations of the risk alleles with obesity and related quantitative traits, respectively. Neither of
the SNPs was signiﬁcantly associated with obesity, BMI or waist circumference under the additive genetic
model (P > 0.05). However, we observed an interaction between rs6232 and age on the level of BMI (P 5
0.010) and risk of obesity (P 5 0.020). The rs6232 SNP was associated with BMI (P 5 0.021) and obesity
(P 5 0.022) in the younger individuals [less than median age (59 years)], but not among the older age
group (P 5 0.81 and P 5 0.68 for BMI and obesity, respectively). In conclusion, our data suggest that the
PCSK1 rs6232 and rs6235 SNPs are not major contributors to common obesity in the general population.
However, the effect of rs6232 may be age-dependent.
INTRODUCTION
Obesity is a leading risk factor for several common diseases
such as type 2 diabetes, cardiovascular disease and cancer
(1). As its prevalence keeps growing rapidly in both developed
and developing countries, the prevention of obesity is now a
major challenge for clinicians and public health policy
makers worldwide (2–4). Obesity has a strong genetic basis
(5,6), but the detection of speciﬁc genetic risk variants has
proven difﬁcult. Recently, genome-wide association studies
have been successful in identifying at least 16 obesity suscep-
tibility loci (7–12). Despite robust associations, these loci
explain less than 2% of the individual variation in the risk
of obesity (11). Furthermore, for most of these loci, the func-
tional role remains to be elucidated.
The candidate gene approach, where promising genes are
investigated on the basis of etiological understanding of disease,
has not been very successful in identifying obesity susceptibility
genes. Recently, however, Benzinou et al.( 1 3 )w a sa b l et o
detect highly signiﬁcant associations between the non-
synonymous rs6232 (N221D) and rs6235 (S690T) SNPs in the
prohormone convertase 1/3 (PCSK1) gene and the risk of
obesity by using a staged, comprehensive candidate gene
approach. After a systematical screening of the PCSK1 gene for
common variants, Benzinou et al. followed up the
obesity-associated rs6232 and rs6235 SNPs in altogether
seven case control studies and one family study, comprising a
total of 13 659 individuals of European ancestry. Finally, a
meta-analysis of seven of the included cohorts showed that each
additional minor allele of rs6232 or rs6235 was associated with
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increase in the risk of obesity, respectively (13).
The PCSK1 gene encodes the prohormone convertase 1/3
enzyme, expressed in neuroendocrine cells, that converts pro-
hormones into functional hormones which regulate energy
metabolism. Mutations in the PCSK1 gene have been found
to cause monogenic obesity (14,15,16). Furthermore, four
genome-wide linkage studies have suggested an association
with the common 5.6 Mb interval on chromosome 5q contain-
ing the PCSK1 gene and obesity-associated traits (17–20).
The N221D substitution, encoded by rs6232, is located in
the catalytic domain of prohormone convertase 1/3, immedi-
ately adjacent to the N222D substitution, which leads to
maturity-onset obesity and increased body fat content in
homozygous mutant mice (21). The N221D substitution is
also located near to two other polymorphic sites (Q250stop
and A213del) which, respectively, truncate the prohormone
convertase and delete a highly conserved alanine residue
near the catalytically critical His208 residue (15). In vitro,
N221D substitution moderately reduces the activity of the pro-
hormone convertase (13).
The rs6235 SNP, encoding S690T, is highly correlated with
another non-synonymous SNP rs6234 that encodes Q665E.
Both substitutions are located in the C-terminal region of the
protein, which has been shown to be important for correct tar-
geting and speciﬁcity of the prohormone convertase 1/3 and its
sorting in secretory granules (22). The Q665E–S690T cluster
has not, however, been found to alter the activity of the con-
vertase (13,16) or its maturation and secretion (13).
A recent meta-analysis of genome-wide association studies
in a total of 32 387 individuals found a weak association of
rs6232 with BMI (P ¼ 0.03 in the appropriate direction),
whereas no data was available for rs6234/rs6235 or for
obesity risk as an outcome (11). A replication in the
population-based Northern Swedish Health and Disease
(NSHED) study could not conﬁrm association between
rs6235 and obesity [odds ratio (OR) 1.05, P ¼ 0.30] among
1723 non-diabetic Swedes (23), and no data for the rs6232
SNP was reported. The ﬁndings thus require further replication
in large-scale populations sufﬁciently powered to identify the
initially observed effect sizes.
The aim of this study was to investigate whether the rs6232
and rs6235 polymorphisms in the PCSK1 gene are associated
with obesity and obesity-related phenotypes in a population-
based cohort comprising 20 249 individuals of European
descent from Norfolk, UK.
RESULTS
The minor alleles of rs6232 and rs6235 SNPs in the PCSK1
gene were not associated with an increased risk of obesity in
comparisons between obese versus non-obese individuals or
between obese versus normal-weight individuals in any of
the tested obesity categories under the additive genetic
model (Tables 1 and 2). Consistently, no associations were
observed between the rs6232 and rs6235 SNPs and the
obesity-related quantitative traits (BMI, waist circumference)
(Table 3). None of the associations were attenuated by the
individuals’ physical activity levels (Pinteraction . 0.10).
We found a signiﬁcant interaction between the rs6232 SNP
and age on the risk of obesity in comparisons between obese
versus normal weight individuals (P ¼ 0.020). Therefore, we
additionally analysed the association of the rs6232 SNP with
obesity in the younger and older individuals separately, strati-
ﬁed by the median age (59 years) of the cohort. The rs6232
SNP was associated with obesity in the younger age group
(OR 1.24, 95% CI 1.03–1.50; P ¼ 0.022), but not among
the older individuals (OR 0.96, 95% CI 0.80–1.16; P ¼
0.68) (Table 2). Consistently, we found a signiﬁcant inter-
action between age and the rs6232 SNP on the level of BMI
(P ¼ 0.010). The rs6232 SNP was associated with BMI
among the younger individuals (b ¼ 0.28+0.12, P ¼
0.021), but not in the older age group (b ¼ 20.03+0.11;
P ¼ 0.81) (Table 3). No signiﬁcant interaction between age
and the rs6235 SNP on the level of obesity as a binary trait
was found in comparisons between obese versus non-obese
(P ¼ 0.43) or obese versus normal weight (P ¼ 0.58) individ-
uals. The rs6235 SNP did neither interact with age on BMI
(P ¼ 0.75) or waist circumference (P ¼ 0.65).
No signiﬁcant interactions between the rs6232 or rs6235
SNPs and sex were found (Pinteraction . 0.05 in all tested
models). However, when comparing obese versus normal
weight individuals, the rs6235 minor allele was associated
with a higher risk of obesity in women (OR 1.10, 95% CI
1.00–1.20; P ¼ 0.046), but not in men (OR ¼ 1.02, 95% CI
1.01–1.03; P ¼ 0.76). We also found a signiﬁcant association
of the rs6232 SNP with waist circumference in women (b ¼
0.74+0.33; P ¼ 0.023), but not in men (b ¼ 0.053+0.29;
P ¼ 0.86). No other signiﬁcant associations of the rs6232 or
rs6235 SNPs with obesity or associated traits were found in
men or women.
Our study had a 99.9% power to detect OR 1.34 with rs6232
and OR 1.22 with rs6235 when comparing class I obese
(BMI   30 kg/m
2) individuals to non-obese (BMI , 30 kg/
m
2) individuals under an additive model and signiﬁcance
level of 0.05. Thus, our analyses had sufﬁcient power to
detect similar effect sizes as previously reported using the
class I obesity threshold. (13). The power to detect the ORs
1.34 and 1.22 with rs6232 and rs6235 in the comparisons
between class II obese (BMI   35 kg/m
2) and non-obese indi-
viduals were 63.2% for rs6232 and 33.0% for rs6235. The
power to detect the same ORs when comparing class III
obese (BMI   40 kg/m
2) individuals to non-obese individuals
was 20.0 and 11.4% for rs6232 and rs6235, respectively.
To provide a pooled OR for the association of the rs6235
polymorphism with obesity in a total of 12 439 individuals
included in the present study and the NSHED study (23), we
performed a meta-analysis by the inverse variance method.
We used ORs derived from comparisons between obese and
normal weight individuals because they were available from
both studies. We observed a non-signiﬁcant OR of 1.05
(95% CI 0.99–1.11; P ¼ 0.11). Additionally, we performed
a meta-analysis to provide a pooled effect size for the associ-
ation of the rs6232 SNP with BMI in the present study
and in the 32 387 individuals of the recent genome-wide
meta-analysis on BMI (11). As there was an overlap of 2168
individuals between the present study and the genome-wide
meta-analysis, these individuals were removed from the
present data while calculating effect size for the meta-analysis.
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ation of the rs6232 SNP with BMI were not available in the
publication by Willer et al. (11), and they were thus estimated
on the basis of the association P-value and number of individ-
uals. The pooled effect size we calculated for the rs6232 SNP
among the total of 50 468 individuals was 0.17 kg/m
2 per
allele (P ¼ 0.004).
DISCUSSION
Recently, a meta-analysis comprising more than 13 000 indi-
viduals from one family-based and seven case–control
cohorts found signiﬁcant association of the rs6232 (N221D)
and rs6235 (S690T) SNPs in the PCSK1 gene with the risk
of obesity. The present study aimed to replicate these ﬁndings
in a large population-based cohort of European ancestry from
Norfolk, UK. Despite the fact that we had sufﬁcient power to
replicate the previously reported results, we did not detect sig-
niﬁcant associations between the rs6232 and rs6235 poly-
morphisms and obesity or obesity-related phenotypes.
However, we observed interactions between the rs6232 SNP
and age on the level of obesity and BMI. The rs6232 SNP
was associated with obesity only among the younger age
group (less than 59 years), but not in the older individuals.
The discrepant ﬁndings between the present study and
Benzinou et al. (13) may in part be explained by differences
in the age of the studied individuals. The study by Benzinou
et al. included three case–control cohorts of children, in
whom genetic inﬂuences on BMI may be stronger than in
Table 1. Association of the rs6232 and rs6235 SNPs with obesity
Odds ratio (95% CI) P-value
rs6232 AA AG GG
Non-obese (BMI , 30 kg/m
2) 15 461 1800 52
Obese (BMI   30 kg/m
2) 2612 311 13 1.05 (0.93–1.19) 0.41
Class II obese (BMI   35 kg/m
2) 465 48 3 0.97 (0.73–1.28) 0.81
Class III obese (BMI   40 kg/m
2) 104 14 0 1.11 (0.65–1.91) 0.70
rs6235 GG GC CC
Non-obese (BMI , 30 kg/m
2) 9074 6764 1228
Obese (BMI   30 kg/m
2) 1521 1202 203 1.03 (0.96–1.09) 0.42
Class II obese (BMI   35 kg/m
2) 278 198 39 1.00 (0.87–1.15) 0.98
Class III obese (BMI   40 kg/m
2) 59 48 11 1.16 (0.87–1.53) 0.31
Obese versus non-obese individuals. All odds ratios and P-values are calculated with non-obese individuals as the reference group and are adjusted for
age and sex. P-values are for the additive genetic model.
Table 2. Association of the rs6232 and rs6235 SNPs with obesity
Odds ratio (95% CI) P-value
rs6232 AA AG GG
All subjects
Normal weight (BMI , 25 kg/m
2) 7113 802 18
Obese (BMI   30 kg/m
2) 2612 311 13 1.09 (0.95–1.24) 0.22
Class II obese (BMI   35 kg/m
2) 465 48 3 1.00 (0.75–1.33) 1.00
Class III obese (BMI   40 kg/m
2) 104 14 0 1.16 (0.67–2.01) 0.60
Age ,59 years
Normal weight (BMI , 25 kg/m
2) 3946 424 9
Obese (BMI   30 kg/m
2) 1172 157 4 1.24 (1.03–1.50) 0.022
Class II obese (BMI   35 kg/m
2) 220 29 1 1.25 (0.85–1.82) 0.26
Class III obese (BMI   40 kg/m
2) 54 9 0 1.45 (0.72–2.90) 0.29
Age  59 years
Normal weight (BMI , 25 kg/m
2) 3167 378 9
Obese (BMI   30 kg/m
2) 1440 154 9 0.96 (0.80–1.16) 0.68
Class II obese (BMI   35 kg/m
2) 245 19 2 0.79 (0.51–1.22) 0.29
Class III obese (BMI   40 kg/m
2) 50 5 0 0.86 (0.35–2.12) 0.74
rs6235 GG GC CC
All subjects
Normal weight (BMI , 25 kg/m
2) 4197 3038 558
Obese (BMI   30 kg/m
2) 1521 1202 203 1.05 (0.98–1.12) 0.20
Class II obese (BMI   35 kg/m
2) 278 198 39 1.01 (0.88–1.17) 0.86
Class III obese (BMI   40 kg/m
2) 59 48 11 1.17 (0.88–1.55) 0.27
Obese versus normal weight individuals. All odds ratios and P-values are calculated with normal weight individuals as the reference group and assuming
additive genetic model. The P-values for the analyses in all subjects are adjusted for age and sex. The P-values for the analyses in age subgroups are
adjusted for sex only. P ¼ 0.020, P ¼ 0.065 and P ¼ 0.32 for the interaction between rs6232 and age (modelled as a continuous variable) on obesity,
class II obesity and class III obesity, respectively.
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40–79 years of age, but the interaction of the rs6232 SNP
with age suggests that rs6232 SNP may be associated with
obesity more strongly or exclusively among younger age
groups. Furthermore, a high number of the obese cases studied
by Benzinou et al.( 1 3 )w e r ec l a s sI I I( B M I   40 kg/m
2)
obese, whereas only 4% of the obese participants of the
present study had such a high BMI. Severely and morbidly
obese individuals are likely to carry more genetic risk variants
for obesity than other individuals, and thus a high number of
such individuals may lead to inﬂated ORs in genetic associ-
ation studies (13). It is also possible that the associations of
the rs6232 and rs6235 SNPs become apparent only among
individuals with severe obesity, and our study was underpow-
ered to detect such effects. Indeed, the ORs were strongest
when class III obese individuals were compared with either
non-obese or normal weight individuals (Tables 1 and 2).
Consistently with the present study, a replication in the
population-based NSHED study did not ﬁnd a signiﬁcant
association for the rs6235 polymorphism with obesity among
1723 individuals (OR 1.05: P ¼ 0.30) or BMI among 3885
individuals (P ¼ 0.59) (23). The pooled OR that we calculated
on the basis of the available data did not suggest a signiﬁcant
association between the rs6235 variant and obesity. Our
meta-analysis on the rs6232 SNP among more than 50 000
individuals, showed a modest association with BMI. The
effect size we meta-analysed for the rs6232 SNP was
0.17 kg/m
2 per allele, which is approximately half of the
effect size of the rs9939609 SNP in the FTO gene, the
strongest common obesity risk variant known so far (11).
The minor allele frequency (MAF) of the rs6232 SNP is,
however, low (5%), and rs6232 is thus likely to provide a
rather weak population-attributable risk on common obesity.
Thus, the rs6232 SNP seems not to be a major contributor to
obesity in the general population.
In summary, although we found an effect in the appropriate
direction, our ﬁndings from the population-based EPIC-
Norfolk study do not support that the rs6232 and rs6235
SNPs of the PCSK1 gene are major contributors to common
obesity in the general population. Further studies are war-
ranted to examine whether common variants in the PCSK1
gene contribute to increased risk of obesity in other popu-
lations, especially among younger age groups.
MATERIALS AND METHODS
The study population included 20 249 individuals (9998 men,
10 251 women) from the EPIC-Norfolk cohort, a population-
based study of men and women aged 40–79 years and
recruited in Norfolk, UK. The study design, methods and
measurements have been described in detail previously (25).
In brief, all participants attended a clinical examination that
included standard anthropometric measurements. Height and
weight were measured with participants dressed in lightweight
clothing without shoes, and BMI was calculated as weight in
kilograms divided by the square of height in meters. Waist cir-
cumference was measured midway between the lowest rib and
the iliac crest to the nearest millimeter at the end of expiration.
Habitual physical activity was assessed using two questions
referring to activity during the past year, described in detail
elsewhere (26). On the basis of these questions, the individuals
were allocated to four categories: inactive, moderately inactive,
moderately active and active. The method has been validated
Table 3. Association of the rs6232 and rs6235 SNPs with obesity-related quantitative traits
b+SE P-value
rs6232 AA AG GG
All subjects
BMI (kg/m
2) 26.31+0.03 26.38+0.08 27.46+0.47 0.12+0.08 0.13
Waist (cm) 88.89+0.08 89.12+0.22 91.83+1.25 0.38+0.22 0.082
Hip (cm) 103.04+0.06 103.09+0.17 105.36+0.97 0.18+0.17 0.28
Waist-to-hip 0.862+0.000 0.864+0.001 0.871+0.007 0.002+0.001 0.092
Age ,59 years
BMI (kg/m
2) 26.00+0.04 26.25+0.12 26.95+0.73 0.28+0.12 0.021
Waist (cm) 87.01+0.11 87.52+0.31 89.49+1.91 0.58+0.32 0.067
Hip (cm) 102.62+0.08 102.88+0.24 104.17+1.48 0.31+0.25 0.21
Waist-to-hip 0.847+0.001 0.850+0.002 0.859+0.011 0.003+0.002 0.076
Age  59 years
BMI (kg/m
2) 26.63+0.04 26.50+0.11 27.87+0.61 20.03+0.11 0.81
Waist (cm) 90.73+0.11 90.70+0.31 93.78+1.66 0.15+0.30 0.61
Hip (cm) 103.44+0.08 103.30+0.24 106.31+1.29 0.06+0.24 0.80
Waist-to-hip 0.877+0.001 0.877+0.002 0.883+0.010 0.001+0.002 0.64
rs6235 GG GC CC
All subjects
BMI (kg/m
2) 26.29+0.04 26.41+0.04 26.32+0.10 0.07+0.04 0.12
Waist (cm) 88.83+0.10 89.07+0.11 89.20+0.27 0.21+0.11 0.064
Hip (cm) 102.99+0.08 103.18+0.09 103.13+0.21 0.13+0.09 0.14
Waist-to-hip 0.862+0.001 0.862+0.001 0.864+0.002 0.001+0.001 0.16
Data are mean+SE. b indicates the difference in trait per copy of the risk allele. P-values are for the additive genetic model. Analyses in all subjects are
adjusted for age and sex. Analyses in age subgroups are adjusted for sex only. P-values for the interactions between rs6232 and age (modelled as a
continuous variable) on BMI, waist circumference, hip circumference and waist-to-hip ratio were 0.010, 0.055, 0.13 and 0.10, respectively.
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independent studies (27,28). The study protocol was approved
by The Norfolk and Norwich Hospital Ethics Committee, and
informed consent was obtained from all participants. Descrip-
tive characteristics of the population are given in Table 4.
Genotyping
Genotyping was performed with Custom TaqMan SNP Geno-
typing Assays (Applied Biosystems, Warrington, UK). The
Assays were carried out on 10 ng of genomic DNA in a
2.5 ml standard 384-well TaqMan assay using a G-Storm
GS4 Thermal Cycler (GRI Ltd, Essex, UK), cycling 958C
for 10 min, and then 40 cycles of 15 s at 928C and 1 min at
548C. The ABI PRISM 7900HT Sequence Detection System
(Applied Biosystems, Warrington, UK) was used for endpoint
detection and allele calling. The call rates were 97.7% for
rs6232 and 96.4% for rs6235. The 864 duplicate controls
used for rs6232 were 98.6% concordant and the 817 duplicates
used for rs6235 were 98.8% concordant. The genotypic distri-
butions of the SNPs did not deviate from the Hardy–Weinberg
equilibrium (P ¼ 0.87 for rs6232; P ¼ 0.24 for rs6235). The
MAFs observed in this study (5.5% for rs6232 G-allele and
27.1% for rs6235 C-allele) were similar to those reported by
Benzinou et al. (13).
Statistical analysis
Logistic regression was used to test for the association
between the PCSK1 SNPs and obesity. Comparisons were
carried out between obese (BMI   30 kg/m
2) versus non-
obese (BMI , 30 kg/m
2) and between obese versus normal
weight (BMI , 25 kg/m
2) individuals separately. In addition,
to see whether the association of the PCSK1 SNPs with
obesity depends on the level of BMI, we compared the
normal weight and non-obese individuals to each class I
obese (BMI   30 kg/m
2), class II obese (BMI   35 kg/m
2)
and class III obese (BMI   40 kg/m
2) categories separately.
Quantitative traits (BMI and waist circumference) were ana-
lysed using generalized linear models among all 20 249 par-
ticipants. Interactions between the SNPs and physical
activity (four categories), sex or age were tested by including
a two-way interaction term (SNP physical activity, SNP sex
or SNP age) into the main effects model. Physical activity
and age were entered into the models as continuous variables.
All analyses were adjusted for age and sex, and the reported
P-values are nominal and two sided. Power calculations
were performed using the Quanto software (http://
hydra.usc.edu/gxe). A likelihood ratio test was performed to
assess Hardy–Weinberg equilibrium. Statistical analyses
were performed with SAS 9.1 (SAS Institute, Cary, NC,
USA) except for the meta-analysis, which was carried out
with Stata 10.1 (Stata Corporation LP, College Station, TX,
USA). The inverse variance method was used to pool ORs
or betas from individual studies.
ACKNOWLEDGEMENTS
This work was supported by program grants from the Medical
Research Council UK and Cancer Research UK; and by
additional support from the European Union; Stroke Associ-
ation; British Heart Foundation; Department of Health; Food
Standards Agency; and the Wellcome Trust.
Conﬂict of Interest statement. None declared.
FUNDING
Funding to pay the Open Access publication charges for this
article was provided by MRC Epidemiology Unit.
REFERENCES
1. Must, A., Spadano, J., Coakley, E.H., Field, A.E., Colditz, G. and Dietz,
W.H. (1999) The disease burden associated with overweight and obesity.
J. Am. Med. Assoc., 282, 1523–1529.
2. Ford, E.S. and Mokdad, A.H. (2008) Epidemiology of obesity in the
Western hemisphere. J. Clin. Endocrinol. Metab., 93, S1–S8.
3. Misra, A. and Khurana, L. (2008) Obesity and the metabolic syndrome in
developing countries. J. Clin. Endocrinol. Metab., 93, S9–S30.
4. Berghofer, A., Pischon, T., Reinhold, T., Apovian, C.M., Sharma, A.M.
and Willich, S.N. (2008) Obesity prevalence from a European perspective:
a systematic review. BMC Public Health, 8, 200.
5. Bell, C.G., Walley, A.J. and Froguel, P. (2005) The genetics of human
obesity. Nat. Rev. Genet., 6, 221–234.
6. Lyon, H.N. and Hirschhorn, J.N. (2005) Genetics of common forms of
obesity: a brief overview. Am. J. Clin. Nutr., 82, 215S–217S.
7. Frayling, T.M., Timpson, N.J., Weedon, M.N., Zeggini, E., Freathy, R.M.,
Lindgren, C.M., Perry, J.R., Elliott, K.S., Lango, H., Rayner, H. et al.
(2007) A common variant in the FTO gene is associated with body mass
index and predisposes to childhood and adult obesity. Science, 316,
889–894.
8. Scuteri, A., Sanna, S., Chen, W.M., Uda, M., Albai, G., Strait, J., Najjar,
S., Nagaraja, R., Orru, M., Usala, M. et al. (2007) Genome-wide
association scan shows genetic variants in the FTO gene are associated
with obesity-related traits. PLoS Genet., 3, e115.
9. Loos, R.J., Lindgren, C.M., Li, S., Wheeler, E., Zhao, J.H., Prokopenko,
I., Inouye, M., Freathy, R.M., Attwood, A.P., Beckmann, J.S. et al. (2008)
Common variants near MC4R are associated with fat mass, weight and
risk of obesity. Nat. Genet., 40, 768–775.
10. Thorleifsson, G., Walters, G.B., Gudbjartsson, D.F., Steinthorsdottir, V.,
Sulem, P., Helgadottir, A., Styrkarsdottir, U., Gretarsdottir, S., Thorlacius,
S., Jonsdottir, I. et al. (2009) Genome-wide association yields new
sequence variants at seven loci that associate with measures of obesity.
Nat. Genet., 41, 18–24.
11. Willer, C.J., Speliotes, E.K., Loos, R.J., Li, S., Lindgren, C.M., Heid,
I.M., Berndt, S.I., Elliott, A.L., Jackson, A.U., Lamina, C. et al.
(2009) Six new loci associated with body mass index highlight a
Table 4. Participant characteristics
Men Women
n 9998 10 251
Age (years) 59.1+9.3 58.6+9.3
BMI (kg/m
2) 26.5+3.3 26.1+4.2
Waist circumference (cm) 95.7+9.7 82.1+10.8
Hip circumference (cm) 102.7+6.3 103.4+9.1
Waist-to-hip ratio 0.93+0.06 0.79+0.06
Normal weight (BMI , 25 kg/m
2) 3330 4603
Overweight (BMI 25–30 kg/m
2) 5363 4017
Class I obese (BMI 30–35 kg/m
2) 1160 1260
Class II obese (BMI 35–40 kg/m
2) 122 276
Class III obese (BMI   40 kg/m
2)2 3 9 5
Data are mean+SD.
3500 Human Molecular Genetics, 2009, Vol. 18, No. 18neuronal inﬂuence on body weight regulation. Nat. Genet., 41,
25–34.
12. Meyre, D., Delplangue, J., Chevre, J.C., Lecoeur, C., Lobbens, S., Gallina,
S., Durand, E., Vatin, V., Degraeve, F., Proenca, C. et al. (2009)
Genome-wide association study for early-onset and morbid adult obesity
identiﬁes three new risk loci in European populations. Nat. Genet., 41,
157–159.
13. Benzinou, M., Creemers, J.W., Choquet, H., Lobbens, S., Dina, C.,
Durand, E., Guerardel, A., Boutin, P., Jouret, B., Heude, B. et al. (2008)
Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat.
Genet., 40, 943–945.
14. Jackson, R.S., Creemers, J.W., Ohaqi, S., Rafﬁn-Sanson, M.L., Sanders,
L., Montaque, C.T., Hutton, C.T. and O’Rahilly, S. (1997) Obesity and
impaired prohormone processing associated with mutations in the human
prohormone convertase 1 gene. Nat. Genet., 16, 303–306.
15. Jackson, R.S., Creemers, J.W., Farooqi, I.S., Rafﬁn-Sanson, M.L., Varro,
A., Dockray, G.J., Holst, J.J., Brubaker, P.L., Corvol, P., Polonsky, K.S.
et al. (2003) Small-intestinal dysfunction accompanies the complex
endocrinopathy of human proprotein convertase 1 deﬁciency. J. Clin.
Invest., 112, 1550–1560.
16. Farooqi, I.S., Volders, K., Stanhope, R., Heuschkel, R., White, A., Lank,
E., Koegh, J., O’Rahilly, S. and Creemers, J.W. (2007) Hyperphagia and
early-onset obesity due to a novel homozygous missense mutation in
prohormone convertase 1/3. J. Clin. Endocrinol. Metab., 92, 3369–3373.
17. Hager, J., Dina, C., Francke, S., Dubois, S., Houari, M., Vatin, V.,
Vaillant, E., Lorentz, N., Basdevant, A., Clement, K. et al. (1998) A
genome-wide scan for human obesity genes reveals a major susceptibility
locus on chromosome 10. Nat. Genet., 20, 304–308.
18. Chagnon, Y.C., Rice, T., Perusse, L., Borecki, I.B., Ho-Kim, M.A.,
Lacaille, M., Pare, C., Bouchard, L., Gagnon, J., Leon, A.S. et al. (2001)
Genomic scan for genes affecting body composition before and after
training in Caucasians from HERITAGE. J. Appl. Physiol., 90,
1777–1787.
19. Bell, C.G., Benzinou, M., Siddiq, A., Lecoeur, C., Dina, C., Lemainque,
A., Clement, K., Basdevant, A., Guy-Grand, B., Mein, C.A. et al. (2004)
Genome-wide linkage analysis for severe obesity in French Caucasians
ﬁnds signiﬁcant susceptibility locus on chromosome 19q. Diabetes, 53,
1857–1865.
20. Chen, G., Adeyemo, A.A., Johnson, T., Zhou, J., Amoah, A., Owusu, S.,
Acheampong, J., Agyenim-Boateng, K., Eghan, B.A., Oli, J. et al. (2005)
A genome-wide scan for quantitative trait loci linked to obesity
phenotypes among West Africans. Int. J. Obes., 29, 255–259.
21. Lloyd, D.J., Bohan, S. and Gekakis, N. (2006) Obesity, hyperphagia and
increased metabolic efﬁciency in Pc1 mutant mice. Hum. Mol. Genet., 15,
1884–1893.
22. Zhou, Y. and Lindberg, I. (1994) Enzymatic properties of
carboxyl-terminally truncated prohormone convertase 1 (PC1/SPC3) and
evidence for autocatalytic conversion. J. Biol. Chem., 269, 18408–18413.
23. Renstro ¨m, F., Payne, F., Nordstro ¨m, A., Brito, E.C., Rolandsson, O.,
Hallmans, G., Barroso, I., Nordstro ¨m, P. and Franks, P.W. GIANT
Consortium (2009) Replication and extension of genome-wide association
study results for obesity in 4,923 adults from Northern Sweden. Hum.
Mol. Genet., January 22 [Epub ahead of print].
24. Wardle, J., Carnell, S., Haworth, C.M.A. and Plomin, R. (2008) Evidence
for a strong genetic inﬂuence on childhood despite the force of the
obesogenic environment. Am. J. Clin. Nutr., 87, 398–404.
25. Day, N., Oakes, S., Luben, R., Khaw, K.T., Bingham, S., Welch, A. and
Wareham, N. (1999) EPIC-Norfolk: study design and characteristics of
the cohort. European Prospective Investigation of Cancer. Br. J. Cancer.,
80 (Suppl. 1), 95–103.
26. McFadden, E., Luben, R., Wareham, N., Bingham, S. and Khaw, K.T.
(2008) Occupational social class, risk factors and cardiovascular disease
incidence in men and women: a prospective study in the European
prospective investigation of cancer and nutrition in Norfolk
(EPIC-Norfolk) cohort. Eur. J. Epidemiol., 23, 449–458.
27. Wareham, N.J., Jakes, R.W., Rennie, K.L., Mitchell, J., Hennings, S. and
Day, N.E. (2002) Validity and repeatability of the EPIC-Norfolk Physical
Activity Questionnaire. Int. J. Epidemiol., 31, 168–174. 2002.
28. Wareham, N.J., Jakes, R.W., Rennie, K.L., Schuit, J., Mitchell, J.,
Hennings, S. and Day, N.E. (2003) Validity and repeatability of a simple
index derived from the short physical activity questionnaire used in the
European Prospective Investigation into Cancer and Nutrition (EPIC)
study. Public Health Nutr., 6, 407–413.
Human Molecular Genetics, 2009, Vol. 18, No. 18 3501